residual fetal membranes after vaginal delivery (defective uterine involution)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) vaginal delivery; (2) Doctors or postpartum B-ultrasound examination, there are remnants of membranes, uterine involution, uterine effusion and other patients; (3) postpartum vaginal bleeding is more than normal menstrual volume; (4) agree to participate in the trial and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) various placental factors such as placenta previa, uterine fibroids and tumors; (2) severe allergies and allergies to motherwort preparations; (3) acute inflammation of the reproductive organs; (4) Those with primary diseases such as severe cardiovascular, liver, kidney and hematopoietic system; (5) Psychiatric patients; (6) Patients who do not cooperate and are unwilling to sign informed consent; (7) The doctor thinks it is not suitable for inclusion in the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lochia;Three diameter line of uterus;Residual membrane area;Infection-related factor;The rate of curettage after incomplete fetal membranes;Hemorrhagic recurrence rate;Incidence of infection; | — |
Secondary
| Measure | Time frame |
|---|---|
| Combined use of other hemostasis drugs;Postpartum temperature changes;Time of hospitalization; | — |
Countries
China
Contacts
West China Second Hospital of Sichuan University